Related Experiment Video
Updated: Oct 1, 2025

A Novel Murine Model of Arteriovenous Fistula Failure: The Surgical Procedure in Detail
Published on: February 3, 2016
[Hemodynamic and cardiovascular implications of arteriovenous fistulas in hemodialysis]
Arnaud Planchat1, Helia Robert-Ebadi2, Patrick Saudan3
1Service de cardiologie, Département de médecine, Hôpitaux universitaires de Genève, 1211 Genève 14.
Insights
Arteriovenous fistulas (AVFs) used for hemodialysis can strain the heart, potentially leading to high-output heart failure. While banding can reduce flow and symptoms, its long-term effectiveness in managing these cardiovascular constraints is limited.
Area of Science:
- Nephrology
- Cardiology
- Vascular Surgery
Background:
- Arteriovenous fistulas (AVFs) are essential for hemodialysis but can cause significant cardiovascular complications.
- AVF creation increases cardiac output and venous return, leading to volume overload, biventricular remodeling, and potential dysfunction.
- High-output heart failure (HOHF) from high-flow AVFs is a recognized clinical entity characterized by hypervolemia and elevated cardiac output.
Purpose of the Study:
- To review the cardiovascular constraints imposed by AVFs in hemodialysis patients.
- To discuss the pathophysiology of high-output heart failure secondary to AVFs.
- To evaluate the efficacy and limitations of current flow reduction procedures, such as vein banding.
Main Methods:
- Literature review of studies investigating AVF complications and their management.
- Analysis of the relationship between AVF flow (Qa > 2 L/min) and the risk of HOHF.
- Examination of the effectiveness of post-anastomotic vein caliber reduction by banding.
Main Results:
- High-flow AVFs (Qa > 2 L/min) are a risk factor for HOHF, especially in susceptible individuals.
- Vein banding can alleviate symptoms and partially reverse structural cardiac abnormalities.
- The benefits of vein banding for flow reduction are often limited in duration.
Conclusions:
- AVF-induced cardiovascular strain, including HOHF, requires careful management.
- While vein banding offers symptomatic relief, its long-term impact on reversing AVF-related cardiac remodeling is limited.
- Further research into more durable interventions for managing high-flow AVF complications is warranted.
Abstract:
Arteriovenous fistula (AVF) remains the vascular access of choice in hemodialysis but generates cardiovascular constraints. Its creation immediately induces an increase in cardiac output. Increased venous return and subsequent volume overload lead to biventricular remodeling, and eventually to dysfunction. High-output heart failure (HOHF) caused by high-flow AVF is a recognized but not strictly defined clinical entity, based on the combination of hypervolemia with an elevated cardiac output. A Qa greater than 2 L/min is a risk factor for HOHF, particularly in susceptible patients. The most used flow reduction procedure is post-anastomotic vein caliber reduction by a banding technique, relieving symptoms and partially reversing previously induced structural abnormalities, but the benefit often remains limited in time.
Related Concept Videos
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications
Hemodialysis III: Nursing Management
Arteries and Arterioles
Cardiac Catheterization I: Pre-Procedure Overview
Heart Failure Drugs: Diuretics

